193 related articles for article (PubMed ID: 9211494)
41. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
[TBL] [Abstract][Full Text] [Related]
42. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat.
Howarth FC; Marzouqi FM; Al Saeedi AM; Hameed RS; Adeghate E
JOP; 2009 Sep; 10(5):485-91. PubMed ID: 19734622
[TBL] [Abstract][Full Text] [Related]
43. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
44. One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
Degn KB; Juhl CB; Sturis J; Jakobsen G; Brock B; Chandramouli V; Rungby J; Landau BR; Schmitz O
Diabetes; 2004 May; 53(5):1187-94. PubMed ID: 15111485
[TBL] [Abstract][Full Text] [Related]
45. Somatostatin and diabetes.
Gerich JE
Am J Med; 1981 Mar; 70(3):619-26. PubMed ID: 6111219
[TBL] [Abstract][Full Text] [Related]
46. Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets.
Wang F; Westermark G; Gasslander T; Permert J
Regul Pept; 1997 Sep; 72(1):61-7. PubMed ID: 9404733
[TBL] [Abstract][Full Text] [Related]
47. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
O'Brien TD; Hayden DW; Johnson KH; Stevens JB
Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345
[TBL] [Abstract][Full Text] [Related]
48. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
49. Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.
Segers O; Somers G
Dig Dis Sci; 1990 Jan; 35(1):20-6. PubMed ID: 2104796
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
[TBL] [Abstract][Full Text] [Related]
51. Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.
Karlsson E; Stridsberg M; Sandler S
Regul Pept; 1996 May; 63(1):39-45. PubMed ID: 8795087
[TBL] [Abstract][Full Text] [Related]
52. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
Sjöholm A; Sandberg E; Ostenson CG; Efendić S
Pancreas; 2000 Apr; 20(3):282-9. PubMed ID: 10766455
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus.
Folli F; La Rosa S; Finzi G; Davalli AM; Galli A; Dick EJ; Perego C; Mendoza RG
Diabetes Obes Metab; 2018 Sep; 20 Suppl 2():137-144. PubMed ID: 30230173
[TBL] [Abstract][Full Text] [Related]
54. Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells.
Hussain MA; Daniel PB; Habener JF
Diabetes; 2000 Oct; 49(10):1681-90. PubMed ID: 11016452
[TBL] [Abstract][Full Text] [Related]
55. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
Grill V; Efendić S
Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
[TBL] [Abstract][Full Text] [Related]
56. Streptozotocin diabetes in the monkey: plasma levels of glucose, insulin, glucagon, and somatostatin, with corresponding morphometric analysis of islet endocrine cells.
Jones CW; Reynolds WA; Hoganson GE
Diabetes; 1980 Jul; 29(7):536-46. PubMed ID: 6103856
[TBL] [Abstract][Full Text] [Related]
57. Chronic exposure of cultured rat pancreatic islets to elevated concentrations of islet amyloid polypeptide (IAPP) causes a decrease in islet DNA content and medium insulin accumulation.
Sandler S; Stridsberg M
Regul Pept; 1994 Sep; 53(2):103-9. PubMed ID: 7831499
[TBL] [Abstract][Full Text] [Related]
58. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
59. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats.
O'Brien TD; Westermark P; Johnson KH
Diabetes; 1991 Dec; 40(12):1701-6. PubMed ID: 1756910
[TBL] [Abstract][Full Text] [Related]
60. Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells.
Johnson KH; O'Brien TD; Jordan K; Westermark P
Am J Pathol; 1989 Aug; 135(2):245-50. PubMed ID: 2675614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
